Home Reports Life Sciences Content

Integrating Transplantation research in Europe : Recent Advances and Future Challenges

next article

17.10.2008

Over the last two years the TRIE initiative, supported by the European Commission, has mobilised stakeholders in Europe’s academic, industrial and patient communities : TRIE aims to define a common approach to respond to important questions that cannot be addressed independently but require scale of research across multiple centres and countries.

The priorities of TRIE are focused in themes common to cell and solid organ transplantation for which integration is critical and which will add value to the development of novel clinical therapies.

On November the 3rd 2008, a high level meeting presenting the conclusions and future concrete actions emerging from TRIE (Transplantation Research Integration across Europe) will take place in Brussels with the participation of Janez Potocnik, John Bowis and Philippe Busquin.

On this occasion we have the pleasure to invite you to a Press Lunch from 12.30 to 14.30 which will be introduced by Philippe Busquin.

During this lunch, Charles Kessler, EU scientific officer, will present an overview of scientific projects launched by the European Commission on Transplantation Immunology.

Prominent stakeholders will explain the advancement of projects integrated in the European Sixth Framework Programme:

•ALLOSTEM is dedicated to the development of new technologies in the field of stem cell transplantation and their clinical applications for the treatment of leukaemia and cancer (http://www.allostem.org/ ), by Pr. Alejandro Madrigal.

•RISET focuses on the establishment of tolerance, defined as the permanent acceptance of the transplant in absence of continuous immunosuppression, and on the translation of the advances in this field into clinical practice and industrial development (http://www.risetfp6.org), by Pr. Michel Goldman.

•XENOME aims to generate the necessary data to allow xenotransplantation to progress towards its initial clinical phase as recent scientific developments indicate that transplantation of organs, tissues or cells between species may become a realistic option resulting in an increased supply of organs (http://www.xenome.eu/), by Pr. Jean-Paul Soulillou.

•TRIE, Transplantation research integration across Europe (http://www.transplantation-research.eu), by Pr. Kathryn Wood.

Furthermore, the participation of Noela and Dimitri Nakos from the Melina Nakos Foundation will allow to get onto the expectations of the patient community.

This press lunch will be held at La Bibliothèque Solvay, Leopold Park, Rue Belliard 137, 1040 Brussels.

Please confirm your participation to this Press Lunch to Audrey Binet by email : abinet@ulb.ac.be

Nancy Dath | Source: alphagalileo
Further information: ulb.ac.be

next article